Union Health secretary Rajesh Bhushan said on Friday that the two Covid -19 vaccines given approval for restricted use would not be available in the open market till the country’s apex drug regulator, Drug Controller General of India{ DCGI }, approved the data sought from their manufactures.

“As of now, no time frame can be set for the rollout of Covid-19 vaccines in the open market. The government’s focus now is only on covering the priority population in the next seven eight months”. He added that no market authorisation has been given to any of the emergency- approved vaccines currently in use in India and abroad. The market authorisation comes after the stipulated follow-up on all the trials phases,” he said. Market authorisation is a pre- requisite to sell vaccines in the open market.

The final data from the vaccines phase- three clinical trials, with a good number of follow-up, should be scrutinised before their full qualification.

Leave a Reply